Supreme Pharma (CSE: SL)  (OTC: SPRWF), which owns 7 Acres, a 342,000 sq. ft. hybrid greenhouse medical cannabis production facility in Ontario licensed by Health Canada under ACMPR, detailed the closing of the third tranche of a capital raise announced in mid-June, raising over $10mm and, cumulatively, almost $15mm.  The offering of units was priced at $.40, each consisting of a common share and a warrant at $0.50. The shares are subject to a four-month hold restriction.

This Financing represents a big step in the growth of Supreme. We are well positioned to complete our Phase 1 expansion of the Hybrid Greenhouse to satisfy wholesale demand in excess of current capacity.

John Fowler, CEO of Supreme Pharma

The participation from existing shareholders, directors, management and local investors from Kincardine demonstrates our stakeholders’ confidence in our organization and business plan. We are fortunate to have such a strong and supportive shareholder base moving forward.

The capital raise by Supreme is one of several that now total over $236mm since the Liberals won control of Parliament in October:

The company, which recently harvested its first crop, was licensed to cultivate in March and, pending completion of an inspection later this year, will begin to sell on a wholesale basis to other licensed producers.

Supreme’s stock, which at $0.65 is up 30% YTD and up more than 100% off the march lows, has rallied recently to set a closing high for 2016 yesterday and a 52-week high earlier today:

Exclusive article by Alan Brochstein, CFA

Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email